• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Research Articles Abstract - 2012 Issues Archive

Research Articles Abstracts - October 13 2012 Issue

Research Articles Abstracts - October 13 2012 Issue

[Source: AMEDEO, homepage: (LINK).]


Research Articles Abstracts - October 13 2012 Issue



Abstracts List
  1. DIMMOCK NJ, Dove BK, Meng B, Scott PD, et al.
  2. STANEKOVA Z, Adkins I, Kosova M, Janulikova J, et al.
  3. BUI VN, Ogawa H, Ngo LH, Baatartsogt T, et al.
  4. YAO Y, Wang H, Chen Q, Zhang H, et al.
  5. FREITAS FT, Souza LR, Azziz-Baumgartner E, Cheng PY, et al.
  6. SOUBIES SM, Hoffmann TW, Croville G, Larcher T, et al.
  7. TRIPATHI S, Tecle T, Verma A, Crouch E, et al.
  8. TAKANO R, Kiso M, Igarashi M, Le QM, et al.
  9. WARREN-GASH C, Hayward AC, Hemingway H, Denaxas S, et al.
  10. SIRIWARDENA AN.
  11. WU P, Goldstein E, Ho LM, Yang L, et al.
  12. MOSS RB, Hansen C, Sanders RL, Hawley S, et al.
  13. HIRSCH MS.
  14. SAKABE S, Takano R, Nagamura-Inoue T, Yamashita N, et al.
  15. CHOI SM, Xie H, Campbell AP, Kuypers J, et al.
  16. HSU WB, Shih JL, Shih JR, Du JL, et al.
  17. TENG Q, Ji X, Li G, Li X, et al.
  18. CHEN C, Zhao G, Gu X, Gu M, et al.
  19. TENG Q, Hu T, Li X, Li G, et al.
  20. WANG B, Chen Q, Chen Z.
  21. ?
  22. CLEGG CH, Roque R, Van Hoeven N, Perrone L, et al.
  23. RENNER B, Reuter T.
  24. PRONKER ES, Claassen E, Osterhaus AD.
  25. PEETERS B, Boer SM, Tjeerdsma G, Moormann R, et al.
  26. NIELSEN AB, Nielsen HS, Nielsen L, Thybo S, et al.
  27. HAMILTON BS, Sun X, Chung C, Whittaker GR, et al.
  28. GUPTA M, Guertin S, Martin S, Omar S, et al.
-
--------
 
Research Articles Abstracts ? October 20 2012 Issue

Research Articles Abstracts ? October 20 2012 Issue

[Source: AMEDEO, homepage: (LINK).]
Research Articles Abstracts ? October 20 2012 Issue



Abstracts List
  1. Ackerman S, Gonzales R.
  2. Hebert C, Beaumont J, Schwartz G, Robicsek A, et al.
    • The influence of context on antimicrobial prescribing for febrile respiratory illness: a cohort study.
  3. Serebryakova MV, Kordyukova LV, Rudneva IA, Kropotkina EA, et al.
    • Mass spectrometry analysis of influenza virus reassortant clones does not reveal an influence of other viral proteins on S-acylation of hemagglutinin.
  4. Dyer C.
    • Catalogue of failures at Manchester hospital contributed to disabled girl's death.
  5. Yan X, Wang Q, Zhang Z, Xie Y, et al.
    • Involvement of non-structural proteins (NS) in influenza A infection and viral tropism.
      • Biochem Biophys Res Commun. 2012 Oct 8. pii: S0006-291X(12)01930.
      • PubMed
      • Related Articles
      • Abstract available
  6. Wongphatcharachai M, Wang P, Enomoto S, Webby RJ, et al.
    • Neutralizing DNA Aptamers Against Swine Influenza H3N2 Viruses.
  7. Tang YW, Lowery KS, Valsamakis A, Schaefer VC, et al.
    • Validation of a PLEX-ID Flu Device for Simultaneous Detection and Identification of Influenza Viruses A and B.
  8. Mooney AJ, Li Z, Gabbard JD, He B, et al.
    • Recombinant PIV5 vaccine encoding the influenza hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.
  9. Xie H, Lin Z, Mosier PD, Desai UR, et al.
    • The Compensatory G88R Change is Essential in Restoring the Normal Functions of Influenza A/WSN/33 Viral Matrix Protein 1 with Disrupted Nuclear Localization Signal.
  10. Li Z, Mooney A, Gabbard JD, Gao X, et al.
    • Recombinant Parainfluenza Virus 5 Expressing HA Of Influenza A Virus H5N1 Protected Mice Against Lethal High Pathogenic Avian Influenza H5N1 Challenge.
  11. Moncorge O, Long JS, Cauldwell AV, Zhou H, et al.
    • Investigation of influenza polymerase activity in pig cells.
  12. Bottcher-Friebertshauser E, Lu Y, Meyer D, Sielaff F, et al.
    • Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections.
  13. Ahmed SS, Themudo GE, Christensen JP, Biswas PK, et al.
    • Molecular epidemiology of circulating highly pathogenic avian influenza (H5N1) virus in chickens, in Bangladesh, 2007-2010.
  14. Wasilewski S, Calder LJ, Grant T, Rosenthal PB, et al.
    • Distribution of surface glycoproteins on influenza A virus determined by electron cryotomography.
  15. Fournier E, Moules V, Essere B, Paillart JC, et al.
    • Interaction network linking the human H3N2 influenza A virus genomic RNA segments.
  16. Kiseleva I, Dubrovina I, Bazhenova E, Fedorova E, et al.
    • Possible outcomes of reassortment in vivo between wild type and live attenuated influenza vaccine strains.
  17. Osterhaus AD.
    • Scientists and policy makers gathered in the post H1N1 pandemic period at the Fourth ESWI Influenza Conference.
  18. Maraskovsky E, Rockman S, Dyson A, Koernig S, et al.
    • Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine.
  19. Avilov SV, Moisy D, Naffakh N, Cusack S, et al.
    • Influenza A virus progeny vRNP trafficking in live infected cells studied with the virus-encoded fluorescently tagged PB2 protein.
  20. Gerlach T, Kuhling L, Uhlendorff J, Laukemper V, et al.
    • Characterization of the neuraminidase of the H1N1/09 pandemic influenza virus.
  21. Esposito S, Marchisio P, Montinaro V, Bianchini S, et al.
    • The immunogenicity and safety of a single 0.5mL dose of virosomal subunit influenza vaccine administered to unprimed children aged >/=6 to <36 months: Data from a randomized, Phase III study.
  22. Sun Y, Sun S, Ma J, Tan Y, et al.
    • Identification and characterization of avian-origin H3N2 canine influenza viruses in northern China during 2009-2010.
-
-------
 
Research Articles Abstracts?October 27 2012 Issue

Research Articles Abstracts?October 27 2012 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?October 27 2012 Issue



This week there are the following abstracts:
  1. Aljadhey H, Alyabsi M, Alrwisan A, Alqahtani N, et al.
    • The safety of H1N1 vaccine in children in Saudi Arabia: a cohort study using modern technology in a developing country.
  2. Ye F, Turner J, Flano E.
    • Contribution of Pulmonary KLRG1high and KLRG1low CD8 T Cells to Effector and Memory Responses during Influenza Virus Infection.
  3. Charrel RN, Salez N.
    • Response letter to rapid diagnosis of influenza: An evaluation of two commercially available RT-PCR assays.
  4. Fraaij PL, van der Vries E, Osterhaus AD.
    • Reply to Chan-Tack: Treatment of severely ill influenza infected patients. Please notice the immune compromised.
  5. Miller MS, Tsibane T, Krammer F, Hai R, et al.
    • 1976 and 2009 H1N1 Influenza Virus Vaccines Boost Anti-Hemagglutinin Stalk Antibodies in Humans.
  6. Capua I, Mercalli A, Pizzuto MS, Romero-Tejeda A, et al.
    • Influenza A viruses grow in human pancreatic cells and cause pancreatitis and diabetes in an animal model.
  7. Gu M, Huang J, Chen Y, Chen J, et al.
    • Genome Sequence of a Natural Reassortant H5N2 Avian Influenza Virus from Domestic Mallard Ducks in Eastern China.
  8. Park SJ, Park BK, Song DS, Poo H, et al.
    • Complete Genome Sequence of a Mammalian Species-Infectious and -Pathogenic H6N5 Avian Influenza Virus without Evidence of Adaptation.
  9. Zhang Y, Teng Q, Ren C, Li G, et al.
    • Complete Genome Sequence of a Novel Reassortant H11N2 Avian Influenza Virus Isolated from a Live Poultry Market in Eastern China.
  10. Choe YJ, Bae GR, Lee DH.
    • No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: An ecological study.
  11. Fukushima W, Ohfuji S, Deguchi M, Kawabata K, et al.
    • Effectiveness of an influenza A (H1N1) 2009 monovalent vaccine among Japanese pregnant women: A prospective observational study assessing antibody efficacy.
  12. Kroeze EJ, Stittelaar KJ, Teeuwsen VJ, Dijkshoorn ML, et al.
    • Consecutive CT in vivo lung imaging as quantitative parameter of influenza vaccine efficacy in the ferret model.
  13. Nfon C, Berhane Y, Pasick J, Kobinger G, et al.
    • Prior infection of chickens with H1N1 avian influenza virus elicits heterologous protection against highly pathogenic H5N2.
  14. Lee BY, Bartsch SM, Willig AM.
    • The economic value of a quadrivalent versus trivalent influenza vaccine.
  15. Tetsutani K, Ishii KJ.
    • Adjuvants in influenza vaccines.
  16. Seo YB, Hong KW, Kim IS, Choi WS, et al.
    • Effectiveness of the influenza vaccine at preventing hospitalization due to acute lower respiratory infection and exacerbation of chronic cardiopulmonary disease in Korea during 2010-2011.
  17. Liu W, Ma MJ, Tang F, He C, et al.
    • Host immune response to A(H1N1)pdm09 vaccination and infection: A one-year prospective study on six cohorts of subjects.
  18. Meijboom MJ, Rozenbaum MH, Benedictus A, Luytjes W, et al.
    • Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands.
  19. Hu W, Chen A, Miao Y, Xia S, et al.
    • Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient.
-
-------
 
Re: Research Articles Abstracts?October 27 2012 Issue

Re: Research Articles Abstracts?October 27 2012 Issue

some notes regarding 2 papers above:


> Gu M, Huang J, Chen Y, Chen J, et al.
> Genome Sequence of a Natural Reassortant H5N2 Avian Influenza
> Virus from Domestic Mallard Ducks in Eastern China.

17,04,20,--,03,--,18,--,19
3,4 are Fujian 2,5,6 are new (mallard not chicken) -
2,5 are close to the mallard-index , 1,7 are from H5N1 ~2002
8 is avian, poultry, distant from the index

------------------------------------------------------------

> Complete Genome Sequence of a Mammalian Species-Infectious and -
> Pathogenic H6N5 Avian Influenza Virus without Evidence of Adaptation.

close to the index : 02,04,05,--,03,--,03,02

so the direct index virus which is probably around in mallards
since centuries, almost unchanged amino acids in the inner segments,
this one can probably already infect humans with suitable HA,NA.
But we hadn't seen this yet in nature - usually it first develops
in poultry (or swine)
----------- well, we knew that already, the 2003 H7N7 outbreak
in Netherlands,Belgium where they culled 30M chickens , had ~100
human infections and one death, was also close to the index
in the inner segments.

Code: 
                                      00235667 00126 01233556 014 0013 3344 2223 0112 
                                      07956280 57709 90739346 141 5905 0445 7781 8347 
                                      99753711 46504 71201536 336 2853 8628 1317 5750 
                                      -------- ----- -------- --- ---- ---- ---- ---- 
                                      DSIRQEED KDDVN TEDIKHLL IAK YRVV NATP KSIS PIIK 
>A/Index/birds/2000(H3N8a)            ........ ..... ........ ... .... .... .... .... 
>A/Netherlands/219/03(H7N7)           YI.KRK.. R.... ....RYI. STR H.M. SVAS .N.. L... 
>A/Ck/Netherlands/1/03(H7N7)          Y.V..... R.... ....RYIF ... H.M. .... .N.. LV.. 
>A/Ck/Netherlands/03010132/2003(H7N7) YI.KR... R.... ....RYI. ST. H.M. SVAS .N.. L... 
>A/aquatic bird/Korea/CN5/2009(H6N5)  ......GN .ENIS IDNVR... --- .KMI ---- R.VF ..VR

common mutations: K391R(3),V105M(5) - V105M(5) is also in BM18 together with K271R(7)
 
Last edited:
Research Articles Abstracts?November 3 2012 Issue

Research Articles Abstracts?November 3 2012 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?November 3 2012 Issue



This week?s abstracts:
  1. Sithisarn P, Michaelis M, Schubert-Zsilavecz M, Cinatl J, et al.
    • Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells.
  2. Barr IG, Jelley LL.
    • The Coming Era of Quadrivalent Human Influenza Vaccines: Who will Benefit?
  3. Englund H, Campe H, Hautmann W.
    • Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season.
  4. Lee YN, Lee DH, Park JK, Yuk SS, et al.
    • Experimental infection and natural contact exposure of ferrets with canine influenza virus (H3N2).
  5. He XS, Sasaki S, Baer J, Khurana S, et al.
    • Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza A/H1N1 vaccine.
  6. Cauldwell AV, Moncorge O, Barclay WS.
    • Unstable polymerase-NP interaction is not responsible for avian influenza polymerase restriction in human cells.
  7. Houser KV, Katz JM, Tumpey TM.
    • Seasonal Trivalent Inactivated Influenza Vaccine Does Not Protect Against Newly Emerging Variants of Influenza A (H3N2v) virus in Ferrets.
  8. Carter DM, Bloom CE, Nascimento EJ, Marques ET, et al.
    • Sequential Seasonal H1N1 Influenza Virus Infections Protect Ferrets Against Novel 2009 H1N1 Influenza.
  9. Huang S, Chen J, Chen Q, Wang H, et al.
    • A second CRM1-dependent nuclear export signal in the influenza A virus NS2 protein (NEP) contributes to the nuclear export of viral ribonucleoproteins.
  10. ...
    • Evaluation of 11 commercially available rapid influenza diagnostic tests - United States, 2011-2012.
  11. Garcia-Sastre A.
    • The neuraminidase of bat influenza viruses is not a neuraminidase.
  12. Couch RB, Atmar RL, Keitel WA, Quarles J, et al.
    • Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.
  13. Fox CB, Huynh C, O'Hara MK, Onu A, et al.
    • Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania.
  14. Le Corre N, Thibault F, Noble CP, Meiffredy V, et al.
    • Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial.
  15. Richards KA, Chaves FA, Alam S, Sant AJ, et al.
    • Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins.
-
-------
 
Research Articles Abstracts ? November 10 2012 Issue

Research Articles Abstracts ? November 10 2012 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts ? November 10 2012 Issue



This week?s abstracts:
  1. Xu J, Yang D, Huang D, Xu J, et al.
    • Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
  2. El Moussi A, Ledesma J, Ben Hadj Kacem MA, Pozo F, et al.
    • Haemagglutinin D222G mutation found in a fatal case of pandemic (H1N1) flu in Tunisia.
  3. Fujisaki S, Takashita E, Yokoyama M, Taniwaki T, et al.
    • A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.
      • Biochem Biophys Res Commun. 2012 Nov 3. pii: S0006-291X(12)02087.
      • PubMed
      • Related Articles
      • Abstract available
  4. Tran AT, Cortens JP, Du Q, Wilkins JA, et al.
    • Influenza Virus Induces Apoptosis via BAD-mediated Mitochondria Dysregulation.
  5. Banyai K, Kovacs E, Toth AG, Biksi I, et al.
    • Genome Sequence of a Monoreassortant H1N1 Swine Influenza Virus Isolated from a Pig in Hungary.
  6. Watanabe T, Imai M, Watanabe S, Shinya K, et al.
    • Characterization in vitro and in vivo of pandemic (H1N1) 2009 influenza viruses isolated from patients.
  7. Kulkarni PS, Manjunath K, Agarkhedkar S.
    • Safety and immunogenicity of an adjuvanted whole virion, inactivated A (H1N1) 2009 influenza vaccine in young and elderly adults, and children.
  8. Schwarz TF, Schmoele-Thoma B.
    • Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged >/=65 years.
  9. Shinjo SK, de Moraes JC, Levy-Neto M, Aikawa NE, et al.
    • Pandemic unadjuvanted influenza A (H1N1) vaccine in dermatomyositis and polymyositis: Immunogenicity independent of therapy and no harmful effect in disease.
  10. Gorman JR, Brewer NT, Wang JB, Chambers CD, et al.
    • Theory-based predictors of influenza vaccination among pregnant women.
  11. Gong M, Zhou J, Yang C, Deng Y, et al.
    • Insect cell-expressed hemagglutinin with CpG oligodeoxynucleotides plus alum as an adjuvant is a potential pandemic influenza vaccine candidate.
  12. Landelle C, Vanhems P, Saadatian-Elahi M, Voirin N, et al.
    • Influenza vaccination coverage among patients and healthcare workers in a university hospital during the 2006-2007 influenza season.
  13. Plant EP, Liu TM, Xie H, Ye Z, et al.
    • Mutations to A/Puerto Rico/8/34 PB1 gene improves seasonal reassortant influenza A virus growth kinetics.
  14. Pandolfi E, Carloni E, Marino MG, Ciofi degli Atti ML, et al.
    • Immunization coverage and timeliness of vaccination in Italian children with chronic diseases.
  15. Beato MS, Mancin M, Yang J, Buratin A, et al.
    • Antigenic characterization of recent H5N1 highly pathogenic avian influenza viruses circulating in Egyptian poultry.
  16. Mansbach JM, Piedra PA, Stevenson MD, Sullivan AF, et al.
    • Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation.
  17. Perwitasari O, Yan X, Johnson S, White C, et al.
    • Targeting the Organic Anion Transporter-3 (OAT3) with Probenecid as a Novel Anti-Influenza A Virus Strategy.
-
--------
 
Research Articles Abstracts?November 17 2012 Issue

Research Articles Abstracts?November 17 2012 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?November 17 2012 Issue



This week?s abstracts:
  1. Alby K, Popowitch EB, Miller MB.
    • Comparative evaluation of the Nanosphere Verigene RV+ Assay with the Simplexa Flu A/B & RSV Kit for the detection of influenza and respiratory syncytial viruses.
  2. Hillaire ML, Vogelzang-van Trierum SE, Kreijtz JH, de Mutsert G, et al.
    • Human T cells directed to seasonal influenza A virus cross-react with A(H1N1)pdm09 and swine origin triple reassortant H3N2 influenza viruses.
  3. Nayak JL, Fitzgerald TF, Richards KA, Yang H, et al.
    • CD4 T-cell expansion predicts neutralizing antibody responses to monovalent inactivated pandemic H1N1 influenza vaccine.
  4. Wu NC, Young AP, Dandekar S, Wijersuriya H, et al.
    • Systematic identification of H274Y compensatory mutations in influenza A virus neuraminidase by high-throughput screening.
  5. Cline TD, Karlsson EA, Seufzer BJ, Schultz-Cherry S, et al.
    • The Hemagglutinin Protein of Highly Pathogenic H5N1 Influenza Viruses Overcomes an Early Block in the Replication Cycle to Promote Productive Replication in Macrophages.
  6. Matzinger SR, Carroll TD, C Dutra J, Ma ZM, et al.
    • Myxovirus resistance gene A (MxA) expression suppresses Influenza A virus replication in Interferon-alpha stimulated primate cells.
  7. Partridge J, Kieny MP.
    • Global production capacity of seasonal influenza vaccine in 2011.
  8. Drees M, Tambourelli B, Denstman A, Zhang W, et al.
    • Sustained high influenza vaccination rates and decreased safety concerns among pregnant women during the 2010-2011 influenza season.
  9. Chang YC, Huang N, Chen LS, Hsu SW, et al.
    • Factors affecting repeated influenza vaccination among older people in Taiwan.
  10. Hernandez-Garcia I, Dominguez B, Gonzalez R.
    • Influenza vaccination rates and determinants among Spanish medical students.
  11. Diazgranados CA, Denis M, Plotkin S.
    • Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: A systematic review with meta-analyses of controlled trials.
-
--------
 
Research Articles Abstracts ? November 24 2012 Issue

Research Articles Abstracts ? November 24 2012 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts ? November 24 2012 Issue



This week?s abstracts:
  1. Rosenberger CM, Podyminogin RL, Navarro G, Zhao GW, et al.
    • miR-451 Regulates Dendritic Cell Cytokine Responses to Influenza Infection.
  2. Sundling C, Murillo PM, Soldemo M, Spangberg M, et al.
    • Immunization of macaques with soluble HIV-1 and influenza virus envelope glycoproteins results in a similarly rapid contraction of peripheral B cell responses after boosting.
  3. Hu Y, Liu X, Li S, Guo X, et al.
    • Complete Genome Sequence of a Novel H4N1 Influenza Virus Isolated from a Pig in Central China.
  4. Zou W, Guo X, Li S, Yang Y, et al.
    • Complete Genome Sequence of a Novel Natural Recombinant H5N5 Influenza Virus from Ducks in Central China.
  5. Xie Z, Xie L, Zhou C, Liu J, et al.
    • Complete Genome Sequence Analysis of an H6N1 Avian Influenza Virus Isolated from Guangxi Pockmark Ducks.
  6. Wang N, Zou W, Yang Y, Guo X, et al.
    • Complete Genome Sequence of an H10N5 Avian Influenza Virus Isolated from Pigs in Central China.
  7. Zhao S, Suo L, Jin M.
    • Genetic Characterization of a Novel Recombinant H5N2 Avian Influenza Virus Isolated from Chickens in Tibet.
  8. Okamatsu M, Feng F, Ohyanagi T, Nagahori N, et al.
    • Fluorescence polarization-based assay using N-glycan-conjugated quantum dots for screening in hemagglutinin blockers for influenza A viruses.
  9. Lorieau JL, Louis JM, Schwieters CD, Bax A, et al.
    • pH-triggered, activated-state conformations of the influenza hemagglutinin fusion peptide revealed by NMR.
  10. Wang IK, Lin CL, Chang YC, Lin PC, et al.
    • Effectiveness of influenza vaccination in elderly diabetic patients: A retrospective cohort study.
-
-------
 
Research Articles Abstracts?December 1st 2012 Issue

Research Articles Abstracts?December 1st 2012 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?December 1st 2012 Issue




This week?s abstracts:
  • J Clin Microbiol
    • SU S , Qi W, Chen J, Zhu W, et al
      • Seroepidemiological Evidence of Avian Influenza A Virus Transmission to Pigs in Southern China.
  • J Infect Dis
    • BARAKAT A , Ihazmad H, El Falaki F, Tempia S, et al
      • 2009 Pandemic Influenza A Virus Subtype H1N1 in Morocco, 2009-2010: Epidemiology, Transmissibility, and Factors Associated With Fatal Cases.
    • LUTWAMA JJ , Bakamutumaho B, Kayiwa JT, Chiiza R, et al
      • Clinic- and hospital-based sentinel influenza surveillance, Uganda 2007-2010.
    • MMBAGA VM , Mwasekaga MJ, Mmbuji P, Matonya M, et al
      • Results from the first 30 months of national sentinel surveillance for influenza in Tanzania, 2008-2010.
    • NYATANYI T , Nkunda R, Rukelibuga J, Palekar R, et al
    • WONG KK , Bulimo WD, Magana J, Achilla RA, et al
      • Epidemiology of 2009 Pandemic Influenza A Virus Subtype H1N1 Among Kenyans Aged 2 Months to 18 Years, 2009-2010.
    • ONYANGO CO , Njeru R, Kazungu S, Achilla R, et al
      • Influenza surveillance among children with pneumonia admitted to a district hospital in coastal kenya, 2007-2010.
    • KATZ MA , Lebo E, Emukule G, Njuguna HN, et al
      • Epidemiology, seasonality, and burden of influenza and influenza-like illness in urban and rural kenya, 2007-2010.
    • HERAUD JM , Njouom R, Rousset D, Kadjo H, et al
      • Spatiotemporal circulation of influenza viruses in 5 african countries during 2008-2009: a collaborative study of the institut pasteur international network.
    • BULIMO WD , Achilla RA, Majanja J, Mukunzi S, et al
      • Molecular Characterization and Phylogenetic Analysis of the Hemagglutinin 1 Protein of Human Influenza A Virus Subtype H1N1 Circulating in Kenya During 2007-2008.
    • AYELE W , Demissie G, Kassa W, Zemelak E, et al
      • Challenges of establishing routine influenza sentinel surveillance in ethiopia, 2008-2010.
    • MUYEMBE TAMFUM JJ , Nkwembe E, Bi Shamamba SK, Bankoshi F, et al
      • Sentinel surveillance for influenza-like illness, severe acute respiratory illness, and laboratory-confirmed influenza in kinshasa, democratic republic of congo, 2009-2011.
    • NJOUOM R , Yekwa EL, Cappy P, Vabret A, et al
      • Viral etiology of influenza-like illnesses in cameroon, january-december 2009.
    • MIHIGO R , Torrealba CV, Coninx K, Nshimirimana D, et al
      • 2009 Pandemic Influenza A Virus Subtype H1N1 Vaccination in Africa--Successes and Challenges.
    • THEO A , Liwewe M, Ndumba I, Mupila Z, et al
    • VENTER M , Naidoo D, Pretorius M, Buys A, et al
      • Evolutionary Dynamics of 2009 Pandemic Influenza A Virus Subtype H1N1 in South Africa During 2009-2010.
    • MCANERNEY JM , Cohen C, Moyes J, Besselaar TG, et al
      • Twenty-five Years of Outpatient Influenza Surveillance in South Africa, 1984-2008.
    • ARCHER BN , Timothy GA, Cohen C, Tempia S, et al
      • Introduction of 2009 Pandemic Influenza A Virus Subtype H1N1 Into South Africa: Clinical Presentation, Epidemiology, and Transmissibility of the First 100 Cases.
    • ORELLE A , Razanajatovo NH, Rajatonirina S, Hoffmann J, et al
      • Epidemiological and Virological Characterization of 2009 Pandemic Influenza A Virus Subtype H1N1 in Madagascar.
    • RADIN JM , Katz MA, Tempia S, Talla Nzussouo N, et al
    • CARDOSO Y , Oliveira E, Vasconcelos J, Cohen AL, et al
      • Characteristics of Patients With Influenza-Like Illness, Severe Acture Respiratory Illness, and Laboratory-Confirmed Influenza at a Major Children's Hospital in Angola, 2009-2011.
    • NIANG MN , Dosseh A, Ndiaye K, Sagna M, et al
    • DALHATU IT , Medina-Marino A, Olsen SJ, Hwang I, et al
      • Influenza viruses in Nigeria, 2009-2010: results from the first 17 months of a national influenza sentinel surveillance system.
    • BONNEY JH , Kronmann KC, Lindan CP, Asante IA, et al
      • Virological surveillance of influenza-like illness among children in ghana, 2008-2010.
    • NZUSSOUO NT , Michalove J, Diop OM, Njouom R, et al
      • Delayed 2009 Pandemic Influenza A Virus Subtype H1N1 Circulation in West Africa, May 2009-April 2010.
    • KATZ MA , Schoub BD, Heraud JM, Breiman RF, et al
  • J Virol Methods
    • MORENO A , Lelli D, Brocchi E, Sozzi E, et al
      • Monoclonal antibody-based ELISA for detection of antibodies against H5 avian influenza viruses.
  • PLoS One
    • CHEN Z , Xu P, Salyards GW, Harvey SB, et al
      • Evaluating a Parainfluenza Virus 5-Based Vaccine in a Host with Pre-Existing Immunity against Parainfluenza Virus 5.
    • WU W , Zhang W, Booth JL, Metcalf JP, et al
      • Influenza A(H1N1)pdm09 Virus Suppresses RIG-I Initiated Innate Antiviral Responses in the Human Lung.
    • VAN BOECKEL TP , Thanapongtharm W, Robinson T, Biradar CM, et al
      • Improving Risk Models for Avian Influenza: The Role of Intensive Poultry Farming and Flooded Land during the 2004 Thailand Epidemic.
  • Proc Natl Acad Sci U S A
    • LEE CM , Weight AK, Haldar J, Wang L, et al
      • Polymer-attached zanamivir inhibits synergistically both early and late stages of influenza virus infection.
    • SHAMAN J , Karspeck A
    • SCHMIDT AG , Xu H, Khan AR, O'Donnell T, et al
      • Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody.
  • Vaccine
    • PARIS B , Arahood T, Asche C, Amundson G, et al
      • Voluntary reporting of health care personnel seasonal influenza vaccination rates and the impact of universal policies in Illinois hospitals.
    • ALLERSON M , Deen J, Detmer S, Gramer M, et al
      • The impact of maternally derived immunity on influenza A virus transmission in neonatal pig populations.
    • CIBLAK MA
      • Influenza vaccination in Turkey: Prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate.
-
-------
 
Research Articles Abstracts ? December 8 2012 Issue

Research Articles Abstracts ? December 8 2012 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts ? December 8 2012 Issue




This week?s abstracts:
  • J Immunol
    • HAMADA H , Bassity E, Flies A, Strutt TM, et al
      • Multiple Redundant Effector Mechanisms of CD8+ T Cells Protect against Influenza Infection.
  • J Infect Dis
    • AOKI FY , Hayden FG
      • The beneficial effects of neuraminidase inhibitor drug therapy on severe patient outcomes during the 2009-10 influenza A (H1N1) pandemic.
    • MUTHURI SG , Myles PR, Venkatesan S, Leonardi-Bee J, et al
      • Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-10 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients.
    • HOCKE AC , Berg J, Becher A, Knepper J, et al
    • FUJINO N , Kubo H, Ota C, Suzuki T, et al
      • Increased severity of H1N1 pandemic influenza virus infection in alveolar type II cells from patients with pulmonary fibrosis.
  • J Virol
    • HARTMANN BM , Li W, Jia J, Patil S, et al
      • Mouse dendritic cell influenza virus infectivity is much lower than for human and is hemagglutinin subtype dependent.
    • BLANCO JC , Pletneva LM, Wan H, Araya Y, et al
      • Receptor Characterization and Susceptibility of Cotton Rats to Avian and 2009 Pandemic Influenza strains.
    • BARON J , Tarnow C, Mayoli-Nussle D, Schilling E, et al
    • KAMINSKI MM , Ohnemus A, Staeheli P, Rubbenstroth D, et al
      • Pandemic 2009 H1N1 influenza A virus carrying a Q136K mutation in the neuraminidase gene is resistant to zanamivir but exhibits reduced fitness in the guinea pig transmission model.
  • PLoS One
    • BIALAS KM , Desmet EA, Takimoto T
      • Specific Residues in the 2009 H1N1 Swine-Origin Influenza Matrix Protein Influence Virion Morphology and Efficiency of Viral Spread In Vitro.
    • HO TY , Huang KY, Huang TT, Huang YS, et al
      • The impact of influenza vaccinations on the adverse effects and hospitalization rate in the elderly: a national based study in an asian country.
    • DE LA ROSA-ZAMBONI D , Vazquez-Perez JA, Avila-Rios S, Carranco-Arenas AP, et al
      • Molecular Characterization of the Predominant Influenza A(H1N1)pdm09 Virus in Mexico, December 2011-February 2012.
    • SARNTIVIJAI S , Xiang Z, Shedden KA, Markel H, et al
      • Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines.
    • RATANAKORN P , Wiratsudakul A, Wiriyarat W, Eiamampai K, et al
      • Satellite Tracking on the Flyways of Brown-Headed Gulls and Their Potential Role in the Spread of Highly Pathogenic Avian Influenza H5N1 Virus.
    • PLUMB AW , Patton DT, Seo JH, Loveday EK, et al
      • Interleukin-7, but not thymic stromal lymphopoietin, plays a key role in the T cell response to influenza a virus.
  • Vaccine
    • CHIU PJ , Chen CH, Chih YC
      • Effectiveness of the influenza vaccination program for the elderly in Taiwan.
    • BOYD AC , Ruiz-Hernandez R, Peroval MY, Carson C, et al
      • Towards a universal vaccine for avian influenza: Protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus.
    • DERHOVANESSIAN E , Theeten H, Hahnel K, Van Damme P, et al
      • Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination.
-
-------
 
Research Articles Abstracts?December 15 2012 Issue

Research Articles Abstracts?December 15 2012 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?December 15 2012 Issue




This week?s abstracts:
  • Biochem Biophys Res Commun
    • ZHOU D , Mei Q, Li J, He H, et al
  • Epidemiol Infect
    • BOLLAERTS K , Antoine J, VAN Casteren V, Ducoffre G, et al
  • J Gen Virol
    • RAHIM MN , Selman M, Sauder P, Forbes NE, et al
      • Generation and characterization of a new panel of broadly-reactive monoclonal anti-NS1 antibodies for detection of Influenza A virus.
  • J Immunol
    • LUCIANI F , Sanders MT, Oveissi S, Pang KC, et al
      • Increasing Viral Dose Causes a Reversal in CD8+ T Cell Immunodominance during Primary Influenza Infection due to Differences in Antigen Presentation, T Cell Avidity, and Precursor Numbers.
    • WHEELER JL , Martin KC, Lawrence BP
      • Novel Cellular Targets of AhR Underlie Alterations in Neutrophilic Inflammation and Inducible NO Synthase Expression during Influenza Virus Infection.
    • HUTTER J , Rodig JV, Hoper D, Seeberger PH, et al
      • Toward Animal Cell Culture-Based Influenza Vaccine Design: Viral Hemagglutinin N-Glycosylation Markedly Impacts Immunogenicity.
    • ANDERSON KG , Sung H, Skon CN, Lefrancois L, et al
  • J Infect Dis
    • VIBOUD C , Eisenstein J, Reid AH, Janczewski TA, et al
      • Age and gender mortality profileassociated with the 1918-19 influenza pandemic in Kentucky, USA.
    • KIMBERLIN DW , Acosta EP, Prichard MN, Sanchez PJ, et al
      • Oseltamivir Pharmacokinetics, Dosing, and Resistance in Children From Birth to Two Years of Age with Influenza.
    • YPMA RJ , Jonges M, Bataille A, Stegeman A, et al
      • Genetic data provide evidence for wind-mediated transmission of highly pathogenic avian influenza.
  • J Virol
    • LEON AJ , Banner D, Xu L, Ran L, et al
    • MURAMOTO Y , Noda T, Kawakami E, Akkina R, et al
    • DU L , Jin L, Zhao G, Sun S, et al
      • Identification and Structural Characterization of a Broadly Neutralizing Antibody Targeting a Novel Conserved Epitope on Influenza H5N1 Hemagglutinin.
    • BUKREYEV A , Yang L, Collins PL
      • The secreted G protein of human respiratory syncytial virus antagonizes antibody-mediated restriction of replication involving macrophages and complement.
    • PINILLA LT , Holder BP, Abed Y, Boivin G, et al
      • The H275Y neuraminidase mutation of the pandemic A/H1N1 influenza virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets.
    • LUONGO C , Winter CC, Collins PL, Buchholz UJ, et al
      • Increased genetic and phenotypic stability of a promising live-attenuated respiratory syncytial virus vaccine candidate by reverse genetics.
    • YAMAGUCHI Y , Harker JA, Wang B, Openshaw PJ, et al
      • Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection.
    • PICA N , Langlois RA, Krammer F, Margine I, et al
      • NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge.
    • LIFLAND AW , Jung J, Alonas E, Zurla C, et al
      • Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS.
    • WU W , Tran KC, Teng MN, Heesom KJ, et al
      • The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology.
  • MMWR Morb Mortal Wkly Rep
    • ?
      • Update: influenza activity - United States, september 30-november 24, 2012.
  • N Engl J Med
    • ANDERSON LJ , Baric RS
    • ZAKI AM , van Boheemen S, Bestebroer TM, Osterhaus AD, et al
  • Pediatrics
    • DIAZ PV , Pinto RA, Mamani R, Uasapud PA, et al
      • Increased Expression of the Glucocorticoid Receptor beta in Infants With RSV Bronchiolitis.
  • PLoS One
    • MARGINE I , Martinez-Gil L, Chou YY, Krammer F, et al
      • Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity.
    • LINIGER M , Summerfield A, Ruggli N
      • MDA5 Can Be Exploited as Efficacious Genetic Adjuvant for DNA Vaccination against Lethal H5N1 Influenza Virus Infection in Chickens.
    • PIAGGIO AJ , Shriner SA, Vandalen KK, Franklin AB, et al
      • Molecular Surveillance of Low Pathogenic Avian Influenza Viruses in Wild Birds across the United States: Inferences from the Hemagglutinin Gene.
    • CHAN RW , Leung CY, Nicholls JM, Peiris JS, et al
      • Proinflammatory Cytokine Response and Viral Replication in Mouse Bone Marrow Derived Macrophages Infected with Influenza H1N1 and H5N1 Viruses.
    • ZHAO D , Liang L, Li Y, Jiang Y, et al
      • Phylogenetic and Pathogenic Analyses of Avian Influenza A H5N1 Viruses Isolated from Poultry in Vietnam.
    • YANG P , Ma C, Shi W, Cui S, et al
      • A Serological Survey of Antibodies to H5, H7 and H9 Avian Influenza Viruses amongst the Duck-Related Workers in Beijing, China.
    • SASAKI T , Kubota-Koketsu R, Takei M, Hagihara T, et al
      • Reliability of a Newly-Developed Immunochromatography Diagnostic Kit for Pandemic Influenza A/H1N1pdm Virus: Implications for Drug Administration.
    • GILBERT M , Jambal L, Karesh WB, Fine A, et al
    • NI K , Li S, Xia Q, Zang N, et al
      • Pharyngeal microflora disruption by antibiotics promotes airway hyperresponsiveness after respiratory syncytial virus infection.
  • Proc Natl Acad Sci U S A
    • LIN YP , Xiong X, Wharton SA, Martin SR, et al
      • Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin.
  • Vaccine
    • GREENBERG DP , Robertson CA, Noss MJ, Blatter MM, et al
      • Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults.
    • KING JC JR , Lichenstein R, Magder LS
      • Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012.
    • STEWART AM , Cox MA
      • State law and influenza vaccination of health care personnel.
    • VALOUR F , Benet T, Chidiac C
      • Pandemic A(H1N1)2009 influenza vaccination in Lyon University Hospitals, France: Perception and attitudes of hospital workers.
    • GARLAPATI S , Garg R, Brownlie R, Latimer L, et al
      • Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles.
  • Virology
    • OLDSTONE MB , Teijaro JR, Walsh KB, Rosen H, et al
      • Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection.
-
-------
 
Research Articles Abstracts?December 22 2012 Issue

Research Articles Abstracts?December 22 2012 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?December 22 2012 Issue




This week?s abstracts:
  • Arch Virol
    • GEN F , Yamada S, Kato K, Akashi H, et al
      • Attenuation of an influenza A virus due to alteration of its hemagglutinin-neuraminidase functional balance in mice.
  • J Gen Virol
    • RAN Z , Chen Y, Shen H, Xiang X, et al
      • IN VITRO AND IN VIVO REPLICATION OF INFLUENZA A H1N1 WSN33 VIRUSES WITH DIFFERENT M1 PROTEINS.
  • J Infect Dis
    • GARG S , Moore Z, Lee N, McKenna J, et al
      • A Cluster of Patients Infected with I221V Influenza B Virus Variants with Reduced Oseltamivir Susceptibility--North Carolina and South Carolina, 2010-2011.
  • J Virol
    • HU J , Hu Z, Song Q, Gu M, et al
      • The PA gene-mediated lethal dissemination and excessive innate immune response contribute to the high virulence of H5N1 avian influenza virus in mice.
    • SUN E , He J, Zhuang X
    • ZENG H , Goldsmith C, Maines TR, Belser JA, et al
      • Tropism and Infectivity of Influenza Virus, Including Highly Pathogenic Avian H5N1 Virus in Ferret Tracheal Differentiated Primary Epithelial Cell Cultures.
    • RAMOS I , Carnero E, Bernal-Rubio D, Seibert CW, et al
      • Contribution of dsRNA and CPSF30 Binding Domains of Influenza Virus NS1 to the Inhibition of Type I IFN Production and Activation of Human Dendritic Cells.
  • J Virol Methods
    • WU L , Ding L, Pei Z, Huo X, et al
      • A multiplex reverse transcription-PCR assay for the detection of influenza A virus and differentiation of the H1, H3, H5 and H9 subtypes.
  • Lancet
    • KARESH WB , Dobson A, Lloyd-Smith JO, Lubroth J, et al
  • PLoS One
    • LANDREAU F , Galeano P, Caltana LR, Masciotra L, et al
      • Effects of two commonly found strains of influenza a virus on developing dopaminergic neurons, in relation to the pathophysiology of schizophrenia.
    • QI W , Tian J, Zhang C, He J, et al
      • Potential Role of HPA Axis and Sympathetic Nervous Responses in Depletion of B Cells Induced by H9N2 Avian Influenza Virus Infection.
    • DIMMOCK NJ , Dove BK, Scott PD, Meng B, et al
      • Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza a virus and allows protective immunity to be established.
    • NFON C , Berhane Y, Pasick J, Embury-Hyatt C, et al
      • Prior Infection of Chickens with H1N1 or H1N2 Avian Influenza Elicits Partial Heterologous Protection against Highly Pathogenic H5N1.
    • SUESS T , Remschmidt C, Schink SB, Schweiger B, et al
      • Comparison of Shedding Characteristics of Seasonal Influenza Virus (Sub)Types and Influenza A(H1N1)pdm09; Germany, 2007-2011.
    • RAFIQ S , Russell ML, Webby R, Fonseca K, et al
      • Serological Response to Influenza Vaccination among Children Vaccinated for Multiple Influenza Seasons.
    • COUCH RB , Decker WK, Utama B, Atmar RL, et al
      • Evaluations for in vitro correlates of immunogenicity of inactivated influenza a h5, h7 and h9 vaccines in humans.
    • COUCH RB , Patel SM, Wade-Bowers CL, Nino D, et al
  • Vaccine
    • ALVAREZ P , Zylberman V, Ghersi G, Boado L, et al
      • Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice.
    • PITMAN RJ , Nagy LD, Sculpher MJ
      • Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model.
    • TACKEN MA , Jansen B, Mulder J, Visscher S, et al
      • Pandemic influenza A(H1N1)pdm09 improves vaccination routine in subsequent years: A cohort study from 2009 to 2011.
    • WIJNANS L , Lecomte C, de Vries C, Weibel D, et al
      • The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.
    • SBIDIAN E , Tubach F, Pasquet B, Paul C, et al
      • Factors associated with 2009 monovalent H1N1 vaccine coverage: A cross sectional study of 1308 patients with psoriasis in France.
  • Virus Res
    • PATEL D , Schultz LW, Umland TC
      • Influenza A polymerase subunit PB2 possesses overlapping binding sites for polymerase subunit PB1 and human MAVS proteins.
    • AWEYA JJ , Mak TM, Lim SG, Tan YJ, et al
      • The p7 protein of the hepatitis C virus induces cell death differently from the influenza A virus viroporin M2.
    • MADERA RF , Libraty DH
      • The Role of MyD88 Signaling in Heterosubtypic Influenza A Virus Infections.
-
-------
 
Research Articles Abstracts?December 31 2012 Issue

Research Articles Abstracts?December 31 2012 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?December 31 2012 Issue




This week?s abstracts:
  • Antiviral Res
    • LIU J , Chen P, Jiang Y, Deng G, et al
      • Recombinant duck enteritis virus works as a single-dose vaccine in broilers providing rapid protection against H5N1 influenza infection.
    • WANG D , Sleeman K, Huang W, Nguyen HT, et al
      • Neuraminidase Inhibitor Susceptibility Testing of Influenza Type B Viruses in China during 2010 and 2011 Identifies Viruses with Reduced Susceptibility to Oseltamivir and Zanamivir.
  • J Virol
    • CHEN Z , Zhou M, Gao X, Zhang G, et al
      • A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.
    • SUN Y , Tan Y, Wei K, Sun H, et al
      • Amino acid 316 of hemagglutinin and the neuraminidase stalk length influence virulence of H9N2 influenza virus in chickens and mice.
  • J Virol Methods
    • NGUYEN TT , Kwon HJ, Kim IH, Hong SM, et al
      • Multiplex nested RT-PCR for detecting avian influenza virus, infectious bronchitis virus and Newcastle disease virus.
    • TAKAYAMA I , Nakauchi M, Fujisaki S, Odagiri T, et al
      • Rapid detection of the S247N neuraminidase mutation in influenza A(H1N1)pdm09 virus by one-step duplex RT-PCR assay.
  • Vaccine
    • AMBROSE CS , Wu X
      • The safety and effectiveness of self-administration of intranasal live attenuated influenza vaccine in adults.
    • DIAZGRANADOS CA , Dunning AJ, Jordanov E, Landolfi V, et al
      • High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009-2010 season.
    • NARWANEY KJ , Glanz JM, Norris JM, Fingerlin TE, et al
      • Association of HLA class II genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children.
    • MURATA Y , Catherman SC
      • Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.
-
-------
 
Research Articles Abstracts?January 5 2013 Issue

Research Articles Abstracts?January 5 2013 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts?January 5 2013 Issue




This week?s abstracts:
  • Ann Intern Med
    • MCKITTRICK N , Frank I, Jacobson JM, White CJ, et al
      • Improved Immunogenicity With High-Dose Seasonal Influenza Vaccine in HIV-Infected Persons: A Single-Center, Parallel, Randomized Trial.
  • Antiviral Res
    • TUTYKHINA IL , Sedova ES, Gribova IY, Ivanova TI, et al
      • Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infection.
    • LEANG SK , Deng YM, Shaw R, Caldwell N, et al
      • Influenza antiviral resistance in the Asia-Pacific region during 2011.
    • TILLIB SV , Ivanova TI, Vasilev LA, Rutovskaya MV, et al
      • Formatted single-domain antibodies can protect mice against infection with influenza virus (H5N2).
  • BMJ
    • ARNHEIM-DAHLSTROM L , Hallgren J, Weibull CE, Sparen P, et al
      • Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study.
  • J Clin Microbiol
    • MCLEISH NJ , Witteveldt J, Clasper L, McIntyre C, et al
      • Development and assay of RNA transcripts of enterovirus species A to D, rhinovirus species a to C, and human parechovirus: assessment of assay sensitivity and specificity of real-time screening and typing methods.
    • SCHIBLER M , Yerly S, Vieille G, Docquier M, et al
      • Critical analysis of rhinovirus RNA load quantification by real-time reverse transcription-PCR.
  • J Infect Dis
    • GHEDIN E , Holmes EC, DePasse JV, Pinilla LT, et al
      • Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission.
    • AGOTI CN , Mwihuri AG, Sande CJ, Onyango CO, et al
      • Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya.
  • J Virol
    • JIANG W , Wang Q, Chen S, Gao S, et al
      • Influenza A virus NS1 induces G0/G1 cell cycle arrest by inhibiting the expression and activity of RhoA protein.
    • ROCKMAN S , Brown LE, Barr IG, Gilbertson B, et al
      • Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza in ferrets immunised with seasonal influenza vaccine.
    • DESMET EA , Bussey KA, Stone R, Takimoto T, et al
      • Identification of the N-terminal domain of influenza PA responsible for the suppression of host protein synthesis.
    • SIVAY MV , Baranovich T, Marchenko VY, Sharshov KA, et al
    • BROOKE CB , Ince WL, Wrammert J, Ahmed R, et al
    • COLPITTS CC , Ustinov AV, Epand RF, Epand RM, et al
      • 5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza, hepatitis C and other enveloped viruses.
  • PLoS One
    • MORNER A , Brave A, Kling AM, Kuhlmann-Berenzon S, et al
      • Pandemic Influenza A(H1N1)pdm09 Seroprevalence in Sweden before and after the Pandemic and the Vaccination Campaign in 2009.
    • SONG HO , Kim JH, Ryu HS, Lee DH, et al
      • Polymeric LabChip Real-Time PCR as a Point-of-Care-Potential Diagnostic Tool for Rapid Detection of Influenza A/H1N1 Virus in Human Clinical Specimens.
    • GUPTA V , Dawood FS, Muangchana C, Lan PT, et al
    • JIANG W , Liu S, Hou G, Li J, et al
    • WANG W , Huang B, Jiang T, Wang X, et al
      • Robust Immunity and Heterologous Protection against Influenza in Mice Elicited by a Novel Recombinant NP-M2e Fusion Protein Expressed in E. coli.
    • ZHAI W , Zhang DN, Mai C, Choy J, et al
      • Comparison of different cell substrates on the measurement of human influenza virus neutralizing antibodies.
    • LIU H , Patil HP, de Vries-Idema J, Wilschut J, et al
      • Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100.
    • GLATMAN-FREEDMAN A , Portelli I, Jacobs SK, Mathew JI, et al
      • Attack Rates Assessment of the 2009 Pandemic H1N1 Influenza A in Children and Their Contacts: A Systematic Review and Meta-Analysis.
    • VAN HELDEN MJ , Zaiss DM, Sijts AJ
      • CCR2 Defines a Distinct Population of NK Cells and Mediates Their Migration during Influenza Virus Infection in Mice.
    • RHEDIN S , Hamrin J, Naucler P, Bennet R, et al
      • Respiratory Viruses in Hospitalized Children with Influenza-Like Illness during the H1n1 2009 Pandemic in Sweden.
  • Proc Natl Acad Sci U S A
    • EISEN HN , Chakraborty AK
      • Immunopaleontology reveals how affinity enhancement is achieved during affinity maturation of antibodies to influenza virus.
-
--------
 
Research Articles Abstract - 2012 Issues Archive

This thread contains the index of the weekly abstracts for the 2012.
 
You must log in or register to reply here.
Back
Top